SRXH - Mergers and acquisitions

NORTH PALM BEACH, Fla., Aug. 04, 2026 (GLOBE NEWSWIRE) -- SRX Global Inc. (NYSE:SRXH) (the "Company", or "SRX"), an AI-enabled platform dedicated to generating long-term shareholder value through investments in high-conviction operating companies and strategic assets, today announced that it has acquired a stake in Vistagen Therapeutics, Inc. (Vistagen) (NASDAQ:VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines. The Company views Vistagen shares as undervalued and welcomes constructive engagement with its leadership team and Board of Direc

Company announces name change to SRX Global in conjunction with transaction closingCompany's stock to remain trading on the NYSE American ("NYSE") under ticker symbol "SRXH" NORTH PALM BEACH, Fla., June 18, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company", or "SRX") today announced it has completed the acquisition of EMJ Crypto Technologies, Inc. ("EMJX") and is launching its new AI-driven platform strategy, which will focus on driving returns for shareholders through the allocation of capital into high-conviction operating companies and assets. In conjunction with the transaction closing, the Company has changed its legal name and branding to SRX Global Inc

NORTH PALM BEACH, Fla., June 08, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced acquiring 4.99% of Smartkem, Inc. (NASDAQ:SMTK), a leader in advanced materials, through a shelf take down. In conjunction with the 4.99% of equity, the Company has also purchased convertible preferred securities through a non-brokered private placement. Additional Information and Where to Find It In connection with the proposed transaction between the Company has filed with the SEC a Registration Statement on F

SRXH files Form S-4 with SEC in connection with EMJX merger  SRXH provides update on performance through mid-April with an approximate 3.5% gain in hedging pool, driven by EMJX's algorithm, and an approximate gain of 8% in its long treasury investment holdings NORTH PALM BEACH, Fla., April 16, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE:SRXH) (the "Company") and EMJ Crypto Technologies ("EMJX"), a digital-asset treasury operating platform with which the Company has entered into a definitive merger agreement, today announced acquiring shares in the open market of Compass Inc. and increasing its investment in Opendoor Technologies Inc. Further to additions to its portfolio,